|
| |
BIONEXIA
RAPID TESTS
|
 |
 |
|
|
|
BioNexia®
HCG Combo |
|
|
BioNexia® hCG Combo is a
chromatographic immunoassay (CIA) for the rapid
qualitative detection of hCG in urine and serum samples.
|
|
|
|
 |
|
|
|
|
BioNexia®
Strep A ratio |
|
|
The BioNexia® Strep A
dipstick is an immunologic one-step test kit for quick
and qualitative determination of group A Streptococcus
antigens directly from a throat-swab.
|
|
|
|
 |
|
|
|
|
BioNexia®
pH-Balance |
|
|
One package contains
hygienically packaged test applicators for the
measurement of vaginal pH (see information on the size
of the package on the box), a set of usage instructions
and a pH color scale on the foil bag.
|
|
|
|
 |
|
|
|
|
BioNexia®
Streptokokken A |
|
|
The BioNexia® Strep A
test enables you to proceed a relable and cost-efficient
screening. The ready-to-use BioNexia® kit is a utmost
convenient alternative.
|
|
|
|
 |
|
|
|
|
BioNexia®
Streptokokken B |
|
|
The Bionexia® GBS
cassette is an immunologic one-step test kit for quick
and qualitative determination of group B Streptococcus
antigens (GBS) on swabs from pregnant women or newborns.
|
|
|
|
 |
|
|
|
|
BioNexia®
Hb/Hp Complex |
|
|
Hb/Hp-Complex is a
visual, immunochromatography dual quick double test for
the qualitative detection of human hemoglobin in stool
samples.
|
|
|
|
 |
|
|
|
|
BioNexia®
FOBplus |
|
|
FOBplus is a visual
immunochromatographic quick test for the qualitative
detection of human hemoglobin in stool samples. The test
is only intended for professional in vitro diagnostic
use.
|
|
|
|
 |
|
|
|
|
BioNexia®
Chlamydia Antigen |
|
|
The chlamydia antigen
test is intended for in vitro diagnostic use in the
rapid, qualitative detection of chlamydiae directly from
female endocervical swabs and male urethral swabs and
urine tests.
|
|
|
|
|
or
send us your request by
filling the below form.
|
| |
|
NEWS
|
HHC is pleased to announce that a specific youtube page is now
available. This page will be implemented in the next months and
furnished with short movies presenting our products and relevant
scientific news.
|
HHC in association with Nucleon Ltd is taking part to the 20th UICC
World Cancer Congress from 27 to 31 Auust 2008 in Geneva. Through our
presence (stand n°1116) we will promote the advantages and benefits of
using
Cytoactiv the first prognostic marker for cervical dysplasia.
 |
|
